Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Biomatics Capital is a venture capital firm founded to support the transformation of healthcare and medicine through strategic investments. Established in Seattle, Washington, the firm focuses on the convergence of genomics and digital data to develop therapeutics, diagnostics, and delivery models aimed at improving patient outcomes and reducing costs in healthcare.
Currently, Biomatics Capital operates with a dedicated team and has a notable portfolio that includes significant investments in groundbreaking companies. The firm primarily invests in North America, specifically the United States, and has established a reputation for targeting outlier companies with innovative ideas that have the potential to disrupt existing markets.
Biomatics Capital invests in several key sectors, including digital health, medical technology, gene editing, and proteomics. The firm targets companies at various stages, specifically seed, Series A, and Series B rounds. Their investment strategy emphasizes identifying outlier companies that possess innovative ideas capable of transforming healthcare markets.
The firm’s thesis centers on the intersection of genomics and digital data, focusing on developing therapeutics and diagnostics that enhance patient outcomes. Biomatics Capital seeks to partner with founders who demonstrate a strong vision and the potential to drive significant change in the healthcare landscape.
Biomatics Capital has a notable portfolio that includes:
Emily Leproust - Founder. Emily has a background in biotechnology and has been instrumental in guiding Biomatics Capital's investment strategy. Her expertise includes gene editing and digital health, and she has led significant investments in transformative healthcare companies.
To pitch Biomatics Capital, founders should send their proposals via email to info@biomaticscapital.com. A concise pitch deck that includes the business model, market analysis, and team background is recommended. Response times may vary, so patience is advised after submission.
In 2015, Biomatics Capital led a $120 million Series B round for Editas Medicine, which later achieved a $94.4 million IPO in 2016. This investment highlights the firm's active role in supporting innovative companies in the biotech sector.
What are Biomatics Capital's investment criteria?
Biomatics Capital focuses on innovative companies in the biotech and healthcare sectors, particularly those at the intersection of genomics and digital data. They seek outlier companies with disruptive ideas that can significantly impact existing markets.
How can founders apply or pitch to Biomatics Capital?
Founders can reach out to Biomatics Capital via email at info@biomaticscapital.com. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential for consideration.
What makes Biomatics Capital different from other venture capital firms?
Biomatics Capital differentiates itself by focusing specifically on the convergence of genomics and digital data, targeting companies that are poised to disrupt healthcare markets. Their expertise in these sectors allows them to provide valuable insights and support to portfolio companies.
What is the geographic scope of Biomatics Capital's investments?
The firm primarily invests in North America, with a strong emphasis on the United States. This geographic focus allows them to stay closely connected to the evolving healthcare landscape.
What is the typical check size for investments?
Biomatics Capital invests at various stages, including seed, Series A, and Series B rounds, with check sizes varying based on the stage and potential of the company.
What kind of post-investment involvement does Biomatics Capital have?
Biomatics Capital actively engages with its portfolio companies, providing guidance and support to help them navigate challenges and capitalize on opportunities in the market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.